Form D · Other Health Care
Vyvve, LLC
Norwood, MA · CIK 0002034596
Offering snapshot reported Aug 27, 2024 · SEC filing
- Reported sold
- $3.48M Offering amount: $5M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $34K Reported outside-investor minimum
- First sale
- Mar 29, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 27, 2024 | Initial | $3,475,000 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-522528
Source: Form D, filed Aug 27, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Neil Fawkes | Executive |
| Stephen J Gatto | Director |
| Matthew Hughes | Executive |
| Michael Michienzi | Director |
| Christiaan Thoen | Executive |
| Daniel B Yaroush | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
220 Norwood Park South Suite 100
Norwood, MA, 02062
Norwood, MA, 02062